Z-208
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Z-208, covering 2012-07-03 to 2012-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]